MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMC 1413805)

Published in Proc Natl Acad Sci U S A on February 13, 2006

Authors

Christopher N Davis1, Enrique Mann, M Margarita Behrens, Svetlana Gaidarova, Mitra Rebek, Julius Rebek, Tamas Bartfai

Author Affiliations

1: The Harold L. Dorris Neurological Institute, La Jolla, CA 92037, USA.

Articles citing this

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature (2008) 9.16

Reflex control of immunity. Nat Rev Immunol (2009) 4.57

The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol (2007) 2.22

A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain (2008) 1.64

Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation. J Biol Chem (2008) 1.33

Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model. J Neurosci (2013) 1.32

Molecular mimicry in innate immunity: crystal structure of a bacterial TIR domain. J Biol Chem (2009) 1.29

Innate instruction of adaptive immunity revisited: the inflammasome. EMBO Mol Med (2009) 1.17

A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1. Immunity (2009) 1.14

Targeting TLR/IL-1R signalling in human diseases. Mediators Inflamm (2010) 1.09

TLR8: an innate immune receptor in brain, neurons and axons. Cell Cycle (2007) 1.05

Heterocyclic alpha-helix mimetics for targeting protein-protein interactions. Bioorg Med Chem Lett (2007) 1.02

Negative regulatory approaches to the attenuation of Toll-like receptor signaling. Exp Mol Med (2013) 0.99

Interleukin-1beta mediates the extra-intestinal thrombosis associated with experimental colitis. Am J Pathol (2010) 0.97

Interleukin-1R3 mediates interleukin-1-induced potassium current increase through fast activation of Akt kinase. Proc Natl Acad Sci U S A (2012) 0.93

Computational Modelling of NF-κB Activation by IL-1RI and Its Co-Receptor TILRR, Predicts a Role for Cytoskeletal Sequestration of IκBα in Inflammatory Signalling. PLoS One (2015) 0.88

Distinct control of MyD88 adapter-dependent and Akt kinase-regulated responses by the interleukin (IL)-1RI co-receptor, TILRR. J Biol Chem (2012) 0.86

Contrasting roles of the IL-1 and IL-18 receptors in MyD88-dependent contact hypersensitivity. J Invest Dermatol (2010) 0.85

Toll-like Receptors in the Vascular System: Sensing the Dangers Within. Pharmacol Rev (2016) 0.84

Immune complexes inhibit IL-1 secretion and inflammasome activation. J Immunol (2014) 0.84

Suppression of TLR signaling by targeting TIR domain-containing proteins. Curr Protein Pept Sci (2012) 0.81

Role of lysosomes in silica-induced inflammasome activation and inflammation in absence of MARCO. J Immunol Res (2014) 0.81

Expression of myeloid differentiation factor 88 in neurons is not requisite for the induction of sickness behavior by interleukin-1β. J Neuroinflammation (2012) 0.81

Therapeutic inhibition of pro-inflammatory signaling and toxicity to staphylococcal enterotoxin B by a synthetic dimeric BB-loop mimetic of MyD88. PLoS One (2012) 0.81

Discovery of small molecule inhibitors of MyD88-dependent signaling pathways using a computational screen. Sci Rep (2015) 0.80

Synapse-specific IL-1 receptor subunit reconfiguration augments vulnerability to IL-1β in the aged hippocampus. Proc Natl Acad Sci U S A (2015) 0.80

Fever. ScientificWorldJournal (2010) 0.79

HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia. Cell Rep (2016) 0.76

TIR/BB-loop mimetic AS-1 attenuates cardiac ischemia/reperfusion injury via a caveolae and caveolin-3-dependent mechanism. Sci Rep (2017) 0.75

Brain-borne IL-1 adjusts glucoregulation and provides fuel support to astrocytes and neurons in an autocrine/paracrine manner. Mol Psychiatry (2015) 0.75

Articles cited by this

Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74

Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity (1998) 18.12

Proinflammatory cytokines. Chest (2000) 5.89

Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature (2005) 5.72

Microglia as a source and target of cytokines. Glia (2002) 4.48

The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE (2003) 4.14

Interleukin-1 and neuronal injury. Nat Rev Immunol (2005) 3.85

Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol (1999) 2.86

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature (2002) 2.71

Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol (2000) 2.66

Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur J Immunol (2003) 2.47

Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res (2004) 2.38

Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88. J Biol Chem (2003) 1.81

IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK). Proc Natl Acad Sci U S A (2001) 1.81

Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold. Bioorg Med Chem (2004) 1.77

Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab (1996) 1.72

Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway. J Biol Chem (2005) 1.70

Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav Immun (2003) 1.64

The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. Biochem Soc Trans (2000) 1.54

Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL. J Biol Chem (2004) 1.50

Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation. J Biol Chem (1997) 1.50

A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells. J Biol Chem (2000) 1.46

Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction. J Immunol (2005) 1.44

Modulation of Toll-interleukin 1 receptor mediated signaling. J Mol Med (Berl) (2005) 1.39

Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J Biol Chem (1992) 1.36

Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2/Src-family kinase pathway in cortical neurons. J Neurosci (2002) 1.32

A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses. Proc Natl Acad Sci U S A (2003) 1.23

The role of MyD88-like adapters in Toll-like receptor signal transduction. Biochem Soc Trans (2003) 1.22

Interleukin-1 activates p54 mitogen-activated protein (MAP) kinase/stress-activated protein kinase by a pathway that is independent of p21ras, Raf-1, and MAP kinase kinase. J Biol Chem (1994) 1.10

Innate immune responses to microbial poisons: discovery and function of the Toll-like receptors. Annu Rev Pharmacol Toxicol (2002) 1.06

Interleukin-1beta modulates state-dependent discharge activity of preoptic area and basal forebrain neurons: role in sleep regulation. Eur J Neurosci (2004) 1.04

Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases. Trends Biochem Sci (2002) 1.03

Interleukin-1 beta protects neurons via the interleukin-1 (IL-1) receptor-mediated Akt pathway and by IL-1 receptor-independent decrease of transmembrane currents in vivo. Mol Cell Neurosci (2003) 1.03

Fever: links with an ancient receptor. Curr Biol (1999) 0.99

Functional role of c-Src in IL-1-induced NF-kappa B activation: c-Src is a component of the IKK complex. J Biochem (2005) 0.97

Comparative, behavioural and electrocortical effects of tumor necrosis factor-alpha and interleukin-1 microinjected into the locus coeruleus of rat. Life Sci (1997) 0.96

IL-1beta-induced phosphorylation of PKB/Akt depends on the presence of IRAK-1. Eur J Immunol (2002) 0.96

Interleukin-1beta enhances non-rapid eye movement sleep when microinjected into the dorsal raphe nucleus and inhibits serotonergic neurons in vitro. Eur J Neurosci (2003) 0.95

Phosphatidylinositol 3-kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma Saos-2 cells. J Cell Sci (1999) 0.93

Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I. FEBS Lett (1998) 0.89

Genetic analysis of innate immunity: TIR adapter proteins in innate and adaptive immune responses. Microbes Infect (2004) 0.86

The IL-1 receptor accessory protein is essential for PI 3-kinase recruitment and activation. Biochem Biophys Res Commun (2004) 0.80

Articles by these authors

The role of inflammation in epilepsy. Nat Rev Neurol (2010) 3.89

Transgenic mice with a reduced core body temperature have an increased life span. Science (2006) 3.37

Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol (2005) 2.90

Self-Assembling Capsules. Chem Rev (1997) 2.01

Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response. Br J Haematol (2011) 2.00

A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol (2013) 1.99

A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci (2006) 1.93

Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes (2006) 1.89

Molecular encapsulation. Angew Chem Int Ed Engl (2002) 1.85

Cytokines and fever. Front Biosci (2004) 1.78

Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity. Proc Natl Acad Sci U S A (2008) 1.64

A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain (2008) 1.64

IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun (2011) 1.57

The promise of single-cell sequencing. Nat Methods (2014) 1.51

Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol (2002) 1.42

Neuropeptides: opportunities for drug discovery. Lancet Neurol (2003) 1.41

Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci U S A (2007) 1.40

Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J Neurotrauma (2002) 1.40

Stabilization of labile carbonyl addition intermediates by a synthetic receptor. Science (2007) 1.39

Helical conformation of alkanes in a hydrophobic cavitand. Science (2003) 1.34

Reaction of carboxylic acids and isonitriles in small spaces. J Am Chem Soc (2008) 1.33

Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2/Src-family kinase pathway in cortical neurons. J Neurosci (2002) 1.32

Reaction of isonitriles with carboxylic acids in a cavitand: observation of elusive isoimide intermediates. J Am Chem Soc (2008) 1.29

Anticonvulsant activity of a nonpeptide galanin receptor agonist. Proc Natl Acad Sci U S A (2002) 1.29

IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase. PLoS One (2009) 1.28

Single cell transcriptomics of hypothalamic warm sensitive neurons that control core body temperature and fever response Signaling asymmetry and an extension of chemical neuroanatomy. Pharmacol Ther (2010) 1.27

Downregulation of parvalbumin at cortical GABA synapses reduces network gamma oscillatory activity. J Neurosci (2011) 1.23

A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses. Proc Natl Acad Sci U S A (2003) 1.23

Gender differences in free radical homeostasis during aging: shorter-lived female C57BL6 mice have increased oxidative stress. Aging Cell (2006) 1.22

Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. Proc Natl Acad Sci U S A (2004) 1.22

Brain mitochondrial uncoupling protein 2 (UCP2): a protective stress signal in neuronal injury. Biochem Pharmacol (2002) 1.21

Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice. Naunyn Schmiedebergs Arch Pharmacol (2009) 1.20

Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology (2011) 1.19

Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicity. J Neurochem (2005) 1.18

Insulin causes hyperthermia by direct inhibition of warm-sensitive neurons. Diabetes (2009) 1.16

Structure and binding properties of water-soluble cavitands and capsules. Chem Soc Rev (2006) 1.16

Ceramide mediates the rapid phase of febrile response to IL-1beta. Proc Natl Acad Sci U S A (2006) 1.16

Acetylcholine recognition by a deep, biomimetic pocket. Angew Chem Int Ed Engl (2003) 1.15

Kinetically stable complexes in water: the role of hydration and hydrophobicity. J Am Chem Soc (2004) 1.14

Galanin and its receptors in neurological disorders. Neuromolecular Med (2005) 1.14

Detection of reactive tetrahedral intermediates in a deep cavitand with an introverted functionality. J Am Chem Soc (2007) 1.13

Functional cavitands: chemical reactivity in structured environments. Proc Natl Acad Sci U S A (2005) 1.13

Self-assembled capsules of unprecedented shapes. Angew Chem Int Ed Engl (2011) 1.13

Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex. J Neurophysiol (2008) 1.13

Selectivity in an encapsulated cycloaddition reaction. Org Lett (2002) 1.10

Self-complexed deep cavitands: alkyl chains coil into a nearby cavity. Org Lett (2007) 1.10

Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. Eur J Neurosci (2004) 1.10

Organocatalysis in a synthetic receptor with an inwardly directed carboxylic acid. J Am Chem Soc (2008) 1.08

The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal. Proc Natl Acad Sci U S A (2003) 1.07

Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity. Br J Haematol (2013) 1.07

IL-1beta induces a MyD88-dependent and ceramide-mediated activation of Src in anterior hypothalamic neurons. J Neurochem (2006) 1.06

Guest recognition with micelle-bound cavitands. J Am Chem Soc (2007) 1.05

Reactivity and molecular recognition: amine methylation by an introverted ester. J Am Chem Soc (2003) 1.05

Selective stabilization of self-assembled hydrogen-bonded molecular capsules through π-π interactions. J Am Chem Soc (2012) 1.05

The brain galanin receptors: targets for novel antidepressant drugs. CNS Neurol Disord Drug Targets (2007) 1.04

Fluorescent sensors for organophosphorus nerve agent mimics. J Am Chem Soc (2006) 1.04

Hydrocarbon binding inside a hexameric pyrogallol[4]arene capsule. Org Lett (2005) 1.03

Chemistry and catalysis in functional cavitands. Chem Biol (2009) 1.02

Heterocyclic alpha-helix mimetics for targeting protein-protein interactions. Bioorg Med Chem Lett (2007) 1.02

Neuropeptide expression in rats exposed to chronic mild stresses. Psychopharmacology (Berl) (2004) 1.02

Assembly of resorcinarene capsules in wet solvents. J Am Chem Soc (2003) 1.01

High-throughput FRET assay yields allosteric SERCA activators. J Biomol Screen (2012) 1.01

Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats. Neuropharmacology (2011) 1.00

A synthetic mimic of protein inner space: buried polar interactions in a deep water-soluble host. J Am Chem Soc (2006) 1.00

A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proc Natl Acad Sci U S A (2005) 0.99

Water-stabilized cavitands. J Am Chem Soc (2002) 0.98

Social isomers in encapsulation complexes. J Am Chem Soc (2002) 0.98

Expanded capsules with reversibly added spacers. J Am Chem Soc (2006) 0.98

Synthesis of pyridazine-based scaffolds as alpha-helix mimetics. Org Lett (2007) 0.98

Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5. J Pharmacol Exp Ther (2003) 0.98

G protein-coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice. J Clin Invest (2012) 0.97

Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach. Chem Biodivers (2012) 0.97

Self-fulfilling cavitands: packing alkyl chains into small spaces. Proc Natl Acad Sci U S A (2006) 0.97

A synthetic receptor for choline and carnitine. J Am Chem Soc (2002) 0.97

Sensory neuronal phenotype in galanin receptor 2 knockout mice: focus on dorsal root ganglion neurone development and pain behaviour. Eur J Neurosci (2006) 0.97

Coiled molecules in spring loaded devices. J Am Chem Soc (2006) 0.97

Encapsulation induces helical folding of alkanes. Angew Chem Int Ed Engl (2003) 0.97

Hydrogen-bonded encapsulation complexes in protic solvents. J Am Chem Soc (2004) 0.97

Galanin receptor ligands. Neuropeptides (2005) 0.96

A deep, water-soluble cavitand acts as a phase-transfer catalyst for hydrophobic species. Angew Chem Int Ed Engl (2006) 0.96

Galanin receptors and ligands. Front Endocrinol (Lausanne) (2012) 0.96

Compressed alkanes in reversible encapsulation complexes. Nat Chem (2009) 0.96

A small molecule that mimics the BB-loop in the Toll interleukin-1 (IL-1) receptor domain of MyD88 attenuates staphylococcal enterotoxin B-induced pro-inflammatory cytokine production and toxicity in mice. J Biol Chem (2011) 0.95

Extraction of hydrophobic species into a water-soluble synthetic receptor. J Am Chem Soc (2007) 0.95

Therapeutic potential of new antiinflammatory drugs. Epilepsia (2011) 0.95

Effect of interleukin-18 on mouse core body temperature. Am J Physiol Regul Integr Comp Physiol (2002) 0.95

Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 in obesity and insulin resistance. Swiss Med Wkly (2008) 0.95

Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests. Neuropeptides (2008) 0.95